Supplementary Protection Certificates (SPCs) effectively extend the protection afforded by patents for medicinal products by up to 5 years. This compensates for disadvantages caused by long approval processes: Generally, years pass between a patent application for a new active ingredient and the approval of a drug. Without an extension, the actual patent protection would therefore be reduced so that the time to recoup investments in research might be insufficient.

Continue reading